LUGARESI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 12.868
EU - Europa 10.530
AS - Asia 8.563
SA - Sud America 1.223
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 13
Totale 33.357
Nazione #
US - Stati Uniti d'America 12.658
SG - Singapore 3.280
IT - Italia 2.721
CN - Cina 2.448
UA - Ucraina 1.581
IE - Irlanda 1.346
TR - Turchia 1.094
GB - Regno Unito 1.085
BR - Brasile 985
RU - Federazione Russa 965
VN - Vietnam 818
FR - Francia 755
SE - Svezia 743
DE - Germania 593
FI - Finlandia 363
IN - India 281
CA - Canada 126
NL - Olanda 106
BD - Bangladesh 104
HK - Hong Kong 102
AR - Argentina 89
JP - Giappone 67
ZA - Sudafrica 59
PL - Polonia 58
KR - Corea 56
MX - Messico 53
ES - Italia 50
IQ - Iraq 47
EC - Ecuador 42
IR - Iran 39
ID - Indonesia 33
AT - Austria 31
CZ - Repubblica Ceca 25
IL - Israele 23
CO - Colombia 22
BE - Belgio 21
CL - Cile 21
EU - Europa 21
PY - Paraguay 21
MA - Marocco 19
PK - Pakistan 19
SA - Arabia Saudita 17
LT - Lituania 16
UZ - Uzbekistan 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 14
UY - Uruguay 14
AU - Australia 13
KE - Kenya 13
MY - Malesia 13
NP - Nepal 13
CH - Svizzera 12
TN - Tunisia 12
GR - Grecia 11
EG - Egitto 10
JO - Giordania 10
PH - Filippine 10
RS - Serbia 10
DK - Danimarca 8
PE - Perù 8
AZ - Azerbaigian 7
ET - Etiopia 7
KZ - Kazakistan 7
BH - Bahrain 6
JM - Giamaica 6
CR - Costa Rica 5
MK - Macedonia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HR - Croazia 4
LB - Libano 4
RO - Romania 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
BO - Bolivia 3
GE - Georgia 3
NI - Nicaragua 3
OM - Oman 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
CG - Congo 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MM - Myanmar 2
MZ - Mozambico 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
TL - Timor Orientale 2
AD - Andorra 1
BB - Barbados 1
Totale 33.336
Città #
Singapore 2.347
Jacksonville 1.783
Chandler 1.482
San Jose 1.403
Dublin 1.331
Southend 794
Dallas 706
Ashburn 657
Princeton 616
Izmir 599
Beijing 512
Nanjing 462
Council Bluffs 456
Wilmington 348
Ho Chi Minh City 311
Cambridge 302
Los Angeles 268
Santa Clara 251
The Dalles 215
Tongling 205
Altamura 199
Nanchang 181
New York 171
Hanoi 167
Dearborn 157
Buffalo 154
Ann Arbor 150
Rome 144
Milan 141
Moscow 131
Woodbridge 130
Boardman 96
Hong Kong 94
Shenyang 93
São Paulo 93
Jiaxing 88
Hebei 81
Munich 81
Chieti 75
Kunming 74
Houston 73
Tianjin 70
Redondo Beach 65
Norwalk 64
Hefei 60
Naples 47
Grevenbroich 46
Seoul 46
Hangzhou 45
Tokyo 44
Warsaw 43
Bologna 42
Brooklyn 42
Changsha 42
Florence 41
San Mateo 39
Torino 39
Montreal 38
London 37
Helsinki 36
Toronto 36
Orem 35
Washington 35
Da Nang 34
Haiphong 34
Johannesburg 34
Dong Ket 33
Turin 33
Frankfurt am Main 32
Stockholm 31
Bari 30
Leawood 30
Ardabil 29
Atlanta 29
Chicago 29
Nuremberg 29
Rio de Janeiro 29
Turku 28
Denver 27
Genoa 26
Orange 26
Poplar 26
San Francisco 26
Augusta 25
Boston 25
Chennai 24
Jinan 24
Pisa 23
Verona 23
Seattle 22
Biên Hòa 21
Lanzhou 21
Changchun 20
Mexico City 20
Phoenix 20
Brasília 19
Brno 19
Manchester 19
Salvador 19
Baghdad 18
Totale 19.570
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.792
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 478
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 236
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 223
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 218
Un caso di mieloneuropatia da HTLV- I in Italia 217
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 214
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 182
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 173
Cleavage of cystatin C is not associated with multiple sclerosis 167
IL 13 in multiple sclerosis 166
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 165
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 164
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 162
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 160
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 159
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 158
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 156
Increasing age at disability milestones among MS patients in the MSBase Registry 153
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 152
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 151
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 150
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 148
"Minimal" chronic inflammatory demyelinating polyneuropathy 147
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 145
F response in vascular and degenerative upper motor neuron lesions 145
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 145
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 145
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 142
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 141
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 141
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 140
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 139
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 138
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 138
Effect of TNF intraneural injection into the rat sciatic nerve 137
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 137
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 137
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 136
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 136
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 136
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 136
Chronic inflammatory demyelinating polyneuropathy in diabetes 134
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 134
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 134
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 133
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 133
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 133
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 132
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 132
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 131
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 130
Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy 130
Neurite ottica retrobulbare: studio biometrico del nervo ottico 128
Autoimmunity and interferon beta1B 128
Transdermal scopolamine cycloplegia in juvenile diabetes 127
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 127
Effect of rhTNF-alpha injection into rat sciatic nerve 127
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 127
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 127
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 126
Neurite ottica: relazione tra perimetria, PEV e RMN 125
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 125
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 125
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 125
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 125
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 124
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 124
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 123
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 123
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 123
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 123
Demyelinating motor Guillain-Barré syndrome following Rubella 123
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 122
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 121
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 121
JCV-Ab serostatus in MS patients treated with Natalizumab 121
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 120
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 120
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 120
Interferone beta: effetti collaterali 120
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 120
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 120
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 119
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of an italian cohort of 462 cases 119
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 118
Effect of rhTNF-a injection into rat sciatic nerve 118
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 118
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 117
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 117
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 116
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 116
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 116
Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. 116
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 116
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study 116
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 115
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 115
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 115
Totale 15.785
Categoria #
all - tutte 126.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 0 0 0 0 0 0 127
2021/20221.200 13 21 19 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20254.692 342 773 737 77 87 141 117 261 396 243 572 946
2025/202610.245 819 423 1.353 1.475 821 571 1.440 634 1.102 834 657 116
Totale 33.602